Browse by author
Lookup NU author(s): Professor Allyson PollockORCiD,
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
After a legislative logjam (since 2011) with respect to regulating the pharmaceuticals industry, the new government at the centre has the opportunity to introduce the much-needed changes to the Drugs and Cosmetics Act. The amendment bill, introduced in Parliament on 29 August 2013, aimed to promote rational regulation of safe and effective allopathic drugs. That bill would have been yet another patch on an Act which has already been stretched beyond breaking point. It would have done little to provide a rigorous foundation for putting safety, effectiveness, rationality and need at the heart of the country's drug regulatory system. It is to be hoped that the government will make a complete overhaul of the Act one of its highest priorities.
Author(s): Pollock AM, McGettigan P, Roderick P, Jeffery R, Mahajan R
Publication type: Review
Publication status: Published
Journal: Economic and Political Weekly
Online publication date: 16/08/2014
Acceptance date: 01/01/1900
ISSN (print): 0012-9976
ISSN (electronic): 2349-8846
Publisher: Economic and Political Weekly